Analysis of immunogenicity data is a critical component of vaccine development, providing a biological basis to support any observed protection from vaccination.
BACKGROUND: A timely differential diagnostic is essential to identify the etiology of central nervous system (CNS) infections in children, in order to facilitate targeted treatment, manage patients, and improve clinical outcome.
BACKGROUND: Globally, over four million deaths are attributed to exposure to household air pollution (HAP) annually.
Globally, cholera epidemics continue to challenge disease control.
Despite the availability of effective direct-acting antiviral (DAA) treatments for Hepatitis C virus (HCV) infection, many people remain undiagnosed and untreated.
Waiting has traditionally been considered a passive state and Hage (2009) identified a sense of ‘stuckedness’, as the cornerstones of social life become suspended when liminality turns into protracted waiting (Hage 2009).
Outbreaks of disease in settings affected by crises grow rapidly due to late detection and weakened public health systems.
In 2015, the initiative Expand New Drug Markets for TB (endTB) began, with the objective of reducing barriers to access to the new and repurposed TB drugs. Here we describe the major implementation challenges encountered in 17 endTB countries.
Rift Valley fever (RVF) is an emerging, zoonotic, arboviral hemorrhagic fever threatening livestock and humans mainly in Africa. RVF is of global concern, having expanded its geographical range over the last decades.
